effect of pregabalin in attenuation of laryngoscopic responses in patient undergoing general anaesthesia
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: H953- Accidental puncture and lacerationof ear and mastoid process during a procedureHealth Condition 3: K352- Acute appendicitis with generalized peritonitisHealth Condition 4: K801- Calculus of gallbladder with othercholecystitisHealth Condition 5: S420- Fracture of clavicleHealth Condition 6: O- Medical and SurgicalHealth Condition 7: H708- Other mastoiditis and related conditionsHealth Condition 8: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2023/06/054185
- Lead Sponsor
- Pacific Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients giving valid informed consent.
Patients aged 18 - 60 years.
Patients weighing 50-80 kgs.
Patients belonging to ASA (American society of anesthesiologist) physical status Grade I and II.
Exclusion Criteria
Patient refusal
Patient with ASA grade III or higher
Pregnant or lactating woman.
On treatment with sedatives, hypnotics, antidepressants, antipsychotic medications.
Patients allergic to anaesthetic medications.
History of hepatic, renal dysfunction and Ischaemic heart disease.
Anticipated difficult intubation
Patients weighing less than 50 kgs and more than 80 kgs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Attenuation of hemodynamic response associated with laryngoscopy & intubation. <br/ ><br>Better analgesia. <br/ ><br>Timepoint: 24months
- Secondary Outcome Measures
Name Time Method Better sedation. <br/ ><br>Absence of serious side effects, if any. <br/ ><br>Timepoint: 24months